 |
 |
 |
 |
 |
 |
 |
 |
|
Web Resource Guide
Ulcerative colitis (UC) patients and their loved ones can
educate themselves about UC and, if desired, reach out to
other people who are dealing with this chronic disease.
You can learn more about UC online and find communities of others with the condition. Listed below are a few resources you may find of interest.
Lialda Brochure
Download the Lialda Brochure for more information.
Para información en español sobre Lialda, haga clic aquí.
Lialda Patient Assistance Program
The Lialda Patient Assistance Program offers Lialda at little or no charge to those eligible. Download more information here.
The Crohn's and Colitis Foundation of America
The Crohn's and Colitis Foundation of America (CCFA) is a non-profit, volunteer-driven organization dedicated to finding the cure for
Crohn's disease and UC. The CCFA website provides medical information reviewed by members of CCFA's National Scientific Advisory
Committee. You can also learn about CCFA support groups, events and more.
The Crohn's and Colitis Foundation of America can also help you locate physicians, nurses and other healthcare professionals who are CCFA members. Simply log on to www.ccfa.org/physician/
Website: www.ccfa.org
Mailing Address:
Crohn's & Colitis Foundation of America
386 Park Avenue South
17th Floor
New York, NY 10016
Phone: 800-932-2423
Email: info@ccfa.org
National Digestive Diseases Information Clearinghouse
The National Digestive Diseases Information Clearinghouse (NDDIC) is a service of the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK). The NIDDK is part of the National Institutes of Health of the U.S. Department of Health and Human Services.
Established in 1980, the Clearinghouse provides information about digestive diseases to people with digestive disorders and to their
families, healthcare professionals, and the public. The NDDIC answers inquiries, develops and distributes publications, and works
closely with professional and patient organizations and Government agencies to coordinate resources about digestive diseases.
Publications produced by the Clearinghouse are carefully reviewed by both NIDDK scientists and outside experts.
Website: digestive.niddk.nih.gov
Mailing Address:
National Digestive Diseases Information Clearinghouse
2 Information Way
Bethesda, MD 20892-3570
Email: nddic@info.niddk.nih.gov
The Foundation for Clinical Research in Inflammatory Bowel Disease
The Foundation for Clinical Research in Inflammatory Bowel Disease is a nonprofit organization dedicated to patient and physician
education and support of clinical research into inflammatory bowel diseases (IBD). MyIBD.org is published by the Foundation.
Website: www.myIBD.org
Mailing Address:
Foundation for Clinical Research in IBD
c/o Harris Baio & McCullough
520 South Front Street
Philadelphia, PA 19147
Email: info@myIBD.org
At these websites, you may find UC health articles, medical news and other educational resources, as well as chat rooms, bulletin boards or message boards where people affected by UC and related conditions can share their feelings and life experiences.
HealingWell.com
www.healingwell.com
Colitis Foundation
www.colitisfoundation.com
Yahoo!® Health
health.yahoo.com
Health Forum
ehealthforum.com
HealthBoards
www.healthboards.com
American Medical Association
www.ama-assn.org
For Caregivers
|
You should not take Lialda if you are allergic to salicylates (including mesalamine or aspirin) or to any of the ingredients of Lialda. Tell your doctor if you have a stomach blockage or are allergic to sulfasalazine. Mesalamine has been associated with a syndrome that may be difficult to distinguish from an ulcerative colitis flare-up. If you experience cramping, abdominal pain, bloody diarrhea, fever, headache or rash, talk to your doctor immediately. Some patients taking mesalamine have reported heart-related hypersensitivity reactions, such as inflammation of the heart muscle and inflammation of the lining of the heart. Tell your doctor if you have problems with your liver or kidneys. In worldwide clinical trials, Lialda was generally well tolerated. The most common adverse events were headache and flatulence. As with other medications, some serious side effects may occur. Less than 1% of patients experienced inflammation of the pancreas, which led to discontinuation of therapy with Lialda. Please see Lialda Full Prescribing Information Privacy Policy | Unsubscribe | For Health Care Professionals
|
